发明名称 INDANYLAMINO URACILS AND THEIR USE AS ANTIOXIDANTS AND NEUROPROTECTANTS
摘要 Disclosed are compounds having the structure (Formula I) wherein, R<SUB>1</SUB> is H, NH<SUB>2</SUB>, NH-(C<SUB>1</SUB>-C<SUB>4</SUB>) alkyl, or N-[(C<SUB>1</SUB>-C<SUB>4 </SUB>)alkyl]<SUB>2</SUB>; R<SUB>2</SUB> and R<SUB>3</SUB> are each independently H, (C<SUB>1</SUB>-C<SUB>4</SUB>) alkyl, or structure (Formula II), wherein R<SUB>4</SUB> is H, (C<SUB>1</SUB>-C<SUB>4</SUB>) alkyl, halogen, hydroxy, (C<SUB>1</SUB>-C<SUB>10</SUB>)alkoxy, cyano, nitro, -NR<SUB>5</SUB>R<SUB>6</SUB>, or -OCONR<SUB>7</SUB>R<SUB>8</SUB>; wherein R<SUB>5</SUB> and R<SUB>6</SUB> are each independently H, or a substituted or unsubstituted (C<SUB>1</SUB>-C<SUB>4</SUB>) alkyl; and wherein R<SUB>7</SUB> and R<SUB>8</SUB> are each independently H, or substituted or unsubstituted (C<SUB>1</SUB>-C<SUB>4</SUB>) alkyl or (C<SUB>1</SUB>-C<SUB>10</SUB>)aryl; and wherein only one of R<SUB>2</SUB> and R<SUB>3</SUB> is H, enantiomers, tautomers, and pharmaceutically acceptable salts of the compounds, pharmaceutical compositions containing such compounds or salts, and processes for their preparation. The subject invention also provides methods of alleviating symptoms of neurologic and inflammatory disorders, methods of preventing oxidation of lipids, proteins, or deoxyribonucleic acids on a cellular level, and methods of protecting human red blood cells from lysis by O<SUB>2</SUB> radicals.
申请公布号 WO2006020070(A3) 申请公布日期 2006.04.13
申请号 WO2005US25218 申请日期 2005.07.15
申请人 TEVA PHARMACEUTICAL INDUSTRIES, LTD.;TEVA PHARMACEUTICALS USA, INC. 发明人 SKLARZ, BENJAMIN;FALB, ELIEZER;TOTH, GYORGY;HERZIG, YAACOV;STERLING, JEFFREY
分类号 C07D239/545;A61K31/513 主分类号 C07D239/545
代理机构 代理人
主权项
地址